Current understanding of ovarian aging

Science China Life Sciences

Volumn 55, Issue 8, 2012, Pages 659-669

  Li, Qian ^a   Geng, XiaoDan ^a   Zheng, Wei ^a   Tang, Jie ^a   Xu, Bo ^a   Shi, QingHua ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

assessment; genetic factors; menopause; microenvironment; ovarian aging; pathology

Indexed keywords

ADVANCED GLYCATION END PRODUCT; MITOCHONDRIAL DNA; TELOMERASE;

AGING; ANIMAL; ENDOCRINE GLAND; FEMALE; GENETICS; HUMAN; MENOPAUSE; METABOLISM; MUTATION; OVARY; OVARY FOLLICLE; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

AGING; ANIMALS; DNA, MITOCHONDRIAL; ENDOCRINE GLANDS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MENOPAUSE; MUTATION; OVARIAN FOLLICLE; OVARY; OXIDATIVE STRESS; TELOMERASE;

EID: 84865813341     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-012-4352-5     Document Type: Review

References (165)

1. Templeton A, Morris J K, Parslow W. Factors that affect outcome of in vitro fertilisation treatment. Lancet, 1996, 348: 1402-1406.
2. Baird D T, Collins J, Egozcue J, et al. Fertility and ageing. Hum Reprod Update, 2005, 11: 261-276.
3. Broekmans F J, Knauff E A, te Velde E R, et al. Female reproductive ageing: Current knowledge and future trends. Trends Endocrinol Metab, 2007, 18: 58-65.
4. Djahanbakhch O, Ezzati M, Zosmer A. Reproductive ageing in women. J Pathol, 2007, 211: 219-231.
5. Hansen K R, Knowlton N S, Thyer A C, et al. A new model of reproductive aging: The decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod, 2008, 23: 699-708.
6. McGee E A, Hsueh A J. Initial and cyclic recruitment of ovarian follicles. Endocr Rev, 2000, 21: 200-214.
7. Hirshfield A N. Development of follicles in the mammalian ovary. Int Rev Cytol, 1991, 124: 43-101.
8. Markstrom E, Svensson E, Shao R, et al. Survival factors regulating ovarian apoptosis - dependence on follicle differentiation. Reproduction, 2002, 123: 23-30.
9. te Velde E R, Pearson P L. The variability of female reproductive ageing. Hum Reprod Update, 2002, 8: 141-154.
10. Block E. A quantitative morphological investigation of the follicular system in newborn female infants. Acta anatomica, 1953, 17: 201-206.
11. Alviggi C, Humaidan P, Howles C M, et al. Biological versus chronological ovarian age: Implications for assisted reproductive technology. Reprod Biol Endocrinol, 2009, 7: 101.
12. te Velde E R, Scheffer G J, Dorland M, et al. Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol, 1998, 145: 67-73.
13. Faddy M J, Gosden R G, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: Implications for forecasting menopause. Hum Reprod, 1992, 7: 1342-1346.
14. Klein N A, Soules M R. Endocrine changes of the perimenopause. Clin Obstet Gynecol, 1998, 41: 912-920.
15. Navot D, Bergh P A, Williams M A, et al. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet, 1991, 337: 1375-1377.
16. Faddy M J, Gosden R G. A mathematical model of follicle dynamics in the human ovary. Hum Reprod, 1995, 10: 770-775.
17. Faddy M J. Follicle dynamics during ovarian ageing. Mol Cell Endocrinol, 2000, 163: 43-48.
18. Nikolaou D, Templeton A. Early ovarian ageing: A hypothesis. Detection and clinical relevance. Hum Reprod, 2003, 18: 1137-1139.
19. de Bruin J P, Dorland M, Spek E R, et al. Age-related changes in the ultrastructure of the resting follicle pool in human ovaries. Biol Reprod, 2004, 70: 419-424.
20. Treloar A E. Menstrual cyclicity and the pre-menopause. Maturitas, 1981, 3: 249-264.
21. Battaglia D E, Goodwin P, Klein N A, et al. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod, 1996, 11: 2217-2222.
22. Kuliev A, Cieslak J, Verlinsky Y. Frequency and distribution of chromosome abnormalities in human oocytes. Cytogenet Genome Res, 2005, 111: 193-198.
23. Hunt P A, Hassold T J. Human female meiosis: What makes a good egg go bad? Trends Genet, 2008, 24: 86-93.
24. Pellestor F, Anahory T, Hamamah S. Effect of maternal age on the frequency of cytogenetic abnormalities in human oocytes. Cytogenet Genome Res, 2005, 111: 206-212.
25. Warburton D. Biological aging and the etiology of aneuploidy. Cytogenet Genome Res, 2005, 111: 266-272.
26. Menken J, Trussell J, Larsen U. Age and infertility. Science, 1986, 233: 1389-1394.
27. Howles C M, Kim C H, Elder K. Treatment strategies in assisted reproduction for women of advanced maternal age. Int Surgery, 2006, 91: S37-54.
28. Gougeon A, Ecochard R, Thalabard J C. Age-related changes of the population of human ovarian follicles: Increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol Reprod, 1994, 50: 653-663.
29. van Zonneveld P, Scheffer G J, Broekmans F J M, et al. Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women. Hum Reprod, 2003, 18: 495-501.
30. Santoro N, Isaac B, Neal-Perry G, et al. Impaired folliculogenesis and ovulation in older reproductive aged women. J Clin Endocrinol Metab, 2003, 88: 5502-5509.
31. Treloar A E, Boynton R E, Behn B G, et al. Variation of the human menstrual cycle through reproductive life. Int J Fertil, 1967, 12: 77-126.
32. Yamoto M, Minami S, Nakano R, et al. Immunohistochemical localization of inhibin/activin subunits in human ovarian follicles during the menstrual cycle. J Clin Endocrinol Metab, 1992, 74: 989-993.
33. Schwall R H, Mason A J, Wilcox J N, et al. Localization of inhibin/activin subunit mrnas within the primate ovary. Mol Endocrinol, 1990, 4: 75-79.
34. Roberts V J, Barth S, el-Roeiy A, et al. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab, 1993, 77: 1402-1410.
35. Klein N A, Illingworth P J, Groome N P, et al. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: A study of serum and follicular fluid levels of dimeric inhibin a and b in spontaneous menstrual cycles. J Clin Endocr Metab, 1996, 81: 2742-2745.
36. Klein N A, Houmard B S, Hansen K R, et al. Age-related analysis of inhibin a, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab, 2004, 89: 2977-2981.
37. Danforth D R, Arbogast L K, Mroueh J, et al. Dimeric inhibin: A direct marker of ovarian aging. Fertil Steril, 1998, 70: 119-123.
38. Hurwitz J M, Santoro N. Inhibins, activins, and follistatin in the aging female and male. Semin Reprod Med, 2004, 22: 209-217.
39. Santoro N, Adel T, Skurnick J H. Decreased inhibin tone and increased activin a secretion characterize reproductive aging in women. Fertil Steril, 1999, 71: 658-662.
40. Reame N E, Wyman T L, Phillips D J, et al. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin a may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women. J Clin Endocrinol Metab, 1998, 83: 3302-3307.
41. Randolph J F Jr., Sowers M, Bondarenko I V, et al. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: Effects of ethnicity and age. J Clin Endocrinol Metab, 2004, 89: 1555-1561.
42. Santoro N. The menopausal transition. Am J Med, 2005, 118: 8-13.
43. Burger H G, Hale G E, Robertson D M, et al. A review of hormonal changes during the menopausal transition: Focus on findings from the melbourne women's midlife health project. Hum Reprod Update, 2007, 13: 559-565.
44. Beemsterboer S N, Homburg R, Gorter N A, et al. The paradox of declining fertility but increasing twinning rates with advancing maternal age. Hum Reprod, 2006, 21: 1531-1532.
45. Gleicher N, Weghofer A, Barad D H. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol, 2011, 9: 23.
46. Ferrell R J, Sowers M. Longitudinal, epidemiologic studies of female reproductive aging. Ann N Y Acad Sci, 2010, 1204: 188-197.
47. Younis J S. Ovarian aging: Latest thoughts on assessment and management. Curr Opin Obstet Gynecol, 2011, 23: 427-434.
48. Murabito J M, Yang Q, Fox C, et al. Heritability of age at natural menopause in the framingham heart study. J Clin Endocrinol Metab, 2005, 90: 3427-3430.
49. Torgerson D J, Thomas R E, Reid D M. Mothers and daughters menopausal ages: Is there a link? Eur J Obstet Gynecol Reprod Biol, 1997, 74: 63-66.
50. van Asselt K M, Kok H S, Pearson P L, et al. Heritability of menopausal age in mothers and daughters. Fertil Steril, 2004, 82: 1348-1351.
51. Wicks J, Treloar S A, Martin N G. Using identity-by-de scent information in affected sib pairs to increase the efficiency of genetic association studies. Twin Res, 2004, 7: 211-216.
52. Jagarlamudi K, Reddy P, Adhikari D, et al. Genetically modified mouse models for premature ovarian failure (POF). Mol Cell Endocrinol, 2010, 315: 1-10.
53. Altshuler D, Brooks L D, Chakravarti A, et al. A haplotype map of the human genome. Nature, 2005, 437: 1299-1320.
54. Lakhal B, Laissue P, Braham R, et al. Bmp15 and premature ovarian failure: Causal mutations, variants, polymorphisms? Clin Endocrinol, 2010, 72: 425-426.
55. Willer C J, Scott L J, Bonnycastle L L, et al. Tag snp selection for finnish individuals based on the ceph utah hapmap database. Genet Epidemiol, 2006, 30: 180-190.
56. Hamatani T, Falco G, Carter M G, et al. Age-associated alteration of gene expression patterns in mouse oocytes. Hum Mol Genet, 2004, 13: 2263-2278.
57. Welt C K, Smith P C, Taylor A E. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocr Metab, 2004, 89: 4569-4574.
58. Hsu S Y, Hsueh A J W. Tissue-specific Bcl-2 protein partners in apoptosis: An ovarian paradigm. Physiol Rev, 2000, 80: 593-614.
59. Petros A M, Olejniczak E T, Fesik S W. Structural biology of the Bcl-2 family of proteins. Bba-Mol Cell Res, 2004, 1644: 83-94.
60. He C Y, Kraft P, Chen C, et al. Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet, 2009, 41: 724-728.
61. Stolk L, Zhai G, van Meurs J B J, et al. Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet, 2009, 41: 645-647.
62. Pellestor F, Anahory T, Hamamah S. Effect of maternal age on the frequency of cytogenetic abnormalities in human oocytes. Cytogenet Genome Res, 2005, 111: 206-212.
63. Pellestor F, Andreo B, Anahory T, et al. The occurrence of aneuploidy in human: Lessons from the cytogenetic studies of human oocytes. European J Med Genet, 2006, 49: 103-116.
64. Colbere-Garapin F, Duncan G, Pavio N, et al. An approach to understanding the mechanisms of poliovirus persistence in infected cells of neural or non-neural origin. Clin Diagn Virol, 1998, 9: 107-113.
65. Battaglia D E, Goodwin P, Klein N A, et al. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod, 1996, 11: 2217-2222.
66. Ghosh S, Bhaumik P, Ghosh P, et al. Chromosome 21 non-disjunction and down syndrome birth in an indian cohort: Analysis of incidence and aetiology from family linkage data. Genet Res, 2010, 92: 189-197.
67. Hassold T, Abruzzo M, Adkins K, et al. Human aneuploidy: Incidence, origin, and etiology. Environ Mol Mutag, 1996, 28: 167-175.
68. Macdonald M, Hassold T, Harvey J, et al. The origin of 47, XXY and 47, XXX aneuploidy-heterogeneous mechanisms and role of aberrant recombination. Hum Mol Genet, 1994, 3: 1365-1371.
69. Angell R R. Predivision in human oocytes at meiosis-I - a mechanism for trisomy formation in man. Hum Genet, 1991, 86: 383-387.
70. Petersen M B. Origin and mechanisms of nondisjunction in human autosomal trisomies. Cytogenet Cell Genet, 1999, 85: 21-21.
71. Watanabe Y, Nurse P. Cohesin rec8 is required for reductional chromosome segregation at meiosis. Nature, 1999, 400: 461-464.
72. Trifunovic A, Wredenberg A, Falkenberg M, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature, 2004, 429: 417-423.
73. Seifer D B, DeJesus V, Hubbard K. Mitochondrial deletions in luteinized granulosa cells as a function of age in women undergoing in vitro fertilization. Fertil Steril, 2002, 78: 1046-1048.
74. Tatone C, Carbone M C, Falone S, et al. Age-dependent changes in the expression of superoxide dismutases and catalase are associated with ultrastructural modifications in human granulosa cells. Mol Hum Reprod, 2006, 12: 655-660.
75. Perez G I, Jurisicova A, Matikainen T, et al. A central role for ceramide in the age-related acceleration of apoptosis in the female germline. FASEB J, 2005, 19: 860-862.
76. Perez G I, Tilly J L. Cumulus cells are required for the increased apoptotic potential in oocytes of aged mice. Hum Reprod, 1997, 12: 2781-2783.
77. Gaulden M E. Maternal age effect: The enigma of down syndrome and other trisomic conditions. Mutat Res, 1992, 296: 69-88.
78. Gordo A C, Rodrigues P, Kurokawa M, et al. Intracellular calcium oscillations signal apoptosis rather than activation in in vitro aged mouse eggs. Biol Reprod, 2002, 66: 1828-1837.
79. Eichenlaub-Ritter U, Vogt E, Yin H, et al. Spindles, mitochondria and redox potential in ageing oocytes. Reprod Biomed Online, 2004, 8: 45-58.
80. Klein J, Sauer M V. Assessing fertility in women of advanced reproductive age. Am J Obstet Gynecol, 2001, 185: 758-770.
81. Blasco M A, Gasser S M, Lingner J. Telomeres and telomerase. Genes Dev, 1999, 13: 2353-2359.
82. Greider C W. Telomeres, telomerase and senescence. Bioessays, 1990, 12: 363-369.
83. Harley C B, Futcher A B, Greider C W. Telomeres shorten during aging of human fibroblasts. Nature, 1990, 345: 458-460.
84. Vonzglinicki T, Saretzki G, Docke W, et al. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts-a model for senescence. Exp Cell Res, 1995, 220: 186-193.
85. Collins K. Structure and function of telomerase. Curr Opin Cell Biol, 1996, 8: 374-380.
86. Harrington L A, Greider C W. Telomerase primer specificity and chromosome healing. Nature, 1991, 353: 451-454.
87. Yu G L, Blackburn E H. Developmentally programmed healing of chromosomes by telomerase in tetrahymena. Cell, 1991, 67: 823-832.
88. Keefe D L, Marquard K, Liu L. The telomere theory of reproductive senescence in women. Curr Opin Obstet Gyn, 2006, 18: 280-285.
89. Kinugawa C, Murakami T, Okamura K, et al. Telomerase activity in normal ovaries and premature ovarian failure. Tohoku J Exp Med, 2000, 190: 231-238.
90. Hanna C W, Bretherick K L, Gair J L, et al. Telomere length and reproductive aging. Hum Reprod, 2009, 24: 1206-1211.
91. Butts S, Riethman H, Ratcliffe S, et al. Correlation of telomere length and telomerase activity with occult ovarian insufficiency. J Clin Endocrinol Metab, 2009, 94: 4835-4843.
92. Moore G E. Biochemical and cellular mechanisms of aging and degenerative disease: Excessive, poor-quality caloric intake may deplete essential nutrients and interfere with cellular processes to produce degenerative damage. Med Hypotheses, 2008, 70: 768-775.
93. Yin D, Chen K. The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions. Exp Gerontol, 2005, 40: 455-465.
94. Sohal R S. Role of oxidative stress and protein oxidation in the aging process. Free Radic Biol Med, 2002, 33: 37-44.
95. Agarwal A, Aponte-Mellado A, Premkumar B J, et al. The effects of oxidative stress on female reproduction: A review. Reprod Biol Endocrinol, 2012, 10: 49.
96. Sahin E, Depinho R A. Axis of ageing: Telomeres, p53 and mitochondria. Nat Rev Mol Cell Biol, 2012, 13: 397-404.
97. Miquel J, Economos A C, Fleming J, et al. Mitochondrial role in cell aging. Exp Gerontol, 1980, 15: 575-591.
98. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: Implications for cell death. Ann Rev Pharmacol Toxicol, 2007, 47: 143-183.
99. 2+ transport, permeability transition and oxidative stress in cell death: Implications in cardiotoxicity, neurodegeneration and dyslipidemias. Front Biosci, 2006, 11: 2554-2564.
100. Tatone C, Amicarelli F, Carbone M C, et al. Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update, 2008, 14: 131-142.
101. Wiener-Megnazi Z, Vardi L, Lissak A, et al. Oxidative stress indices in follicular fluid as measured by the thermochemiluminescence assay correlate with outcome parameters in in vitro fertilization. Fertil Steril, 2004, 82: 1171-1176.
102. Tarin J J. Aetiology of age-associated aneuploidy: A mechanism based on the 'free radical theory of ageing'. Hum Reprod, 1995, 10: 1563-1565.
103. Tarin J J. Potential effects of age-associated oxidative stress on mammalian oocytes/embryos. Mol Hum Reprod, 1996, 2: 717-724.
104. Tamura H, Takasaki A, Miwa I, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res, 2008, 44: 280-287.
105. Liu L, Keefe D L. Cytoplasm mediates both development and oxidation-induced apoptotic cell death in mouse zygotes. Biol Reprod, 2000, 62: 1828-1834.
106. Liu L, Trimarchi J R, Keefe D L. Involvement of mitochondria in oxidative stress-induced cell death in mouse zygotes. Biol Reprod, 2000, 62: 1745-1753.
107. Lass A, Skull J, McVeigh E, et al. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod, 1997, 12: 294-297.
108. van Blerkom J. The influence of intrinsic and extrinsic factors on the developmental potential and chromosomal normality of the human oocyte. J Soc Gynecol Investig, 1996, 3: 3-11.
109. Tarin J J, Perez-Albala S, Cano A. Oral antioxidants counteract the negative effects of female aging on oocyte quantity and quality in the mouse. Mol Reprod Dev, 2002, 61: 385-397.
110. Zhang X, Wu X Q, Lu S, et al. Deficit of mitochondria-derived ATP during oxidative stress impairs mouse MII oocyte spindles. Cell Res, 2006, 16: 841-850.
111. Carbone M C, Tatone C, Delle Monache S, et al. Antioxidant enzymatic defences in human follicular fluid: Characterization and age-dependent changes. Mol Hum Reprod, 2003, 9: 639-643.
112. 2 and the acquisition of oxidative tolerance in candida albicans. Yeast, 2003, 20: 1161-1169.
113. Yim M B, Yim H S, Lee C, et al. Protein glycation: Creation of catalytic sites for free radical generation. Ann N Y Acad Sci, 2001, 928: 48-53.
114. Schmidt A M, Yan S D, Yan S F, et al. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta, 2000, 1498: 99-111.
115. Mullarkey C J, Edelstein D, Brownlee M. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun, 1990, 173: 932-939.
116. Sakurai T, Tsuchiya S. Superoxide production from nonenzymatically glycated protein. FEBS Lett, 1988, 236: 406-410.
117. Wen Y, Skidmore J C, Porter-Turner M M, et al. Relationship of glycation, antioxidant status and oxidative stress to vascular endothelial damage in diabetes. Diabetes Obes Metab, 2002, 4: 305-308.
118. Soldatos G, Cooper M E. Advanced glycation end products and vascular structure and function. Curr Hypertens Rep, 2006, 8: 472-478.
119. Frye E B, Degenhardt T P, Thorpe S R, et al. Role of the maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J Biol Chem, 1998, 273: 18714-18719.
120. Kim J, Kim O S, Kim C S, et al. Accumulation of argpyrimidine, a methylglyoxal-derived advanced glycation end product, increases apoptosis of lens epithelial cells both in vitro and in vivo. Exp Mol Med, 2012, 44: 167-175.
121. Mizutani K, Ikeda K, Tsuda K, et al. Inhibitor for advanced glycation end products formation attenuates hypertension and oxidative damage in genetic hypertensive rats. J Hypertens, 2002, 20: 1607-1614.
122. Dixit H, Rao L K, Padmalatha V V, et al. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet, 2006, 119: 408-415.
123. Laissue P, Christin-Maitre S, Touraine P, et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol, 2006, 154: 739-744.
124. Schmidt D, Ovitt C E, Anlag K, et al. The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development, 2004, 131: 933-942.
125. van Blerkom J, Antczak M, Schrader R. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: Association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod, 1997, 12: 1047-1055.
126. Modlich U, Kaup F J, Augustin H G. Cyclic angiogenesis and blood vessel regression in the ovary: Blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest, 1996, 74: 771-780.
127. Redmer D A, Reynolds L P. Angiogenesis in the ovary. Rev Reprod, 1996, 1: 182-192.
128. Huey S, Abuhamad A, Barroso G, et al. Perifollicular blood flow doppler indices, but not follicular po2, pco2, or ph, predict oocyte developmental competence in in vitro fertilization. Fertil Steril, 1999, 72: 707-712.
129. Bhal P S, Pugh N D, Gregory L, et al. Perifollicular vascularity as a potential variable affecting outcome in stimulated intrauterine insemination treatment cycles: A study using transvaginal power doppler. Hum Reprod, 2001, 16: 1682-1689.
130. Borini A, Maccolini A, Tallarini A, et al. Perifollicular vascularity and its relationship with oocyte maturity and IVF outcome. Ann N Y Acad Sci, 2001, 943: 64-67.
131. Amicarelli F, Ragnelli A M, Aimola P, et al. Age-dependent ultrastructural alterations and biochemical response of rat skeletal muscle after hypoxic or hyperoxic treatments. Biochim Biophys Acta, 1999, 1453: 105-114.
132. Vessey M P, Villard-Mackintosh L, Painter R. Epidemiology of endometriosis in women attending family planning clinics. BMJ, 1993, 306: 182-184.
133. Allaire C. Endometriosis and infertility: A review. J Reprod Med, 2006, 51: 164-168.
134. Jacobson T Z, Duffy J M, Barlow D, et al. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev, 2010, CD001398.
135. Islam M N, Islam M M. Biological and behavioural determinants of fertility in bangladesh: 1975-1989. Asia Pac Popul J, 1993, 8: 3-18.
136. McKinlay S M, Brambilla D J, Posner J G. The normal menopause transition. Maturitas, 2008, 61: 4-16.
137. Jensen T K, Henriksen T B, Hjollund N H, et al. Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 danish couples. Am J Epidemiol, 1998, 148: 992-997.
138. Sharara F I, Scott R T Jr., Seifer D B. The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol, 1998, 179: 804-812.
139. Goldin A, Beckman J A, Schmidt A M, et al. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation, 2006, 114: 597-605.
140. Richardson S J, Nelson J F. Follicular depletion during the menopausal transition. Ann N Y Acad Sci, 1990, 592: 13-20; discussion 44-51.
141. Lass A, Silye R, Abrams D C, et al. Follicular density in ovarian biopsy of infertile women: A novel method to assess ovarian reserve. Hum Reprod, 1997, 12: 1028-1031.
142. Lambalk C B, de Koning C H, Flett A, et al. Assessment of ovarian reserve. Ovarian biopsy is not a valid method for the prediction of ovarian reserve. Hum Reprod, 2004, 19: 1055-1059.
143. Hendriks D J, Kwee J, Mol B W J, et al. Ultrasonography as a tool for the prediction of outcome in ivf patients: A comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril, 2007, 87: 764-775.
144. van Rooij I A J, Tonkelaar I, Broekmans F J M, et al. Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause, 2004, 11: 601.
145. Broekmans F J, de Ziegler D, Howles C M, et al. The antral follicle count: Practical recommendations for better standardization. Fertil Steril, 2010, 94: 1044-1051.
146. Younis J S, Haddad S, Matilsky M, et al. Undetectable basal ovarian stromal blood flow in infertile women is related to low ovarian reserve. Gynecol Endocrinol, 2007, 23: 284-289.
147. Robertson D M. Anti-müllerian hormone as a marker of ovarian reserve: An update. Women's Health, 2008, 4: 137-141.
148. Sowers M F R, Eyvazzadeh A D, McConnell D, et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab, 2008, 93: 3478-3483.
149. Sharov A A, Falco G, Piao Y, et al. Effects of aging and calorie restriction on the global gene expression profiles of mouse testis and ovary. BMC Biol, 2008, 6: 24.
150. Welt C K, Smith Z A, Pauler D K, et al. Differential regulation of inhibin a and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development. J Clin Endocr Metab, 2001, 86: 2531-2537.
151. Catteau-Jonard S, Pigny P, Reyss A C, et al. Changes in serum anti-müllerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome. J Clin Endocr Metab, 2007, 92: 4138-4143.
152. Fanchin R, Schonauer L M, Righini C, et al. Serum anti-mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod, 2003, 18: 323-327.
153. Ficicioglu C, Kutlu T, Baglam E, et al. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril, 2006, 85: 592-596.
154. Visser J A, de Jong F H, Laven J S E, et al. Anti-müllerian hormone: A new marker for ovarian function. Reproduction, 2006, 131: 1-9.
155. de Vet A, Laven J S E, de Jong F H, et al. Antimüllerian hormone serum levels: A putative marker for ovarian aging. Fertil Steril, 2002, 77: 357-362.
156. Hagstad A, Johansson S, Wilhelmsson C, et al. Gynaecology of middle-aged women - menstrual and reproductive histories. Maturitas, 1985, 7: 99-113.
157. van Rooij I A J, Broekmans F J M, Scheffer G J, et al. Serum antimüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil Steril, 2005, 83: 979-987.
158. Fanchin R, Taieb J, Lozano D H M, et al. High reproducibility of serum anti-müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod, 2005, 20: 923-927.
159. La Marca A, Sighinolfi G, Radi D, et al. Anti-müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update, 2010, 16: 113-130.
160. Sowers M R, Eyvazzadeh A D, McConnell D, et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab, 2008, 93: 3478-3483.
161. Groome N P, Illingworth P J, O'Brien M, et al. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf), 1994, 40: 717-723.
162. Groome N P, Illingworth P J, O'Brien M, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab, 1996, 81: 1401-1405.
163. Hall J E, Welt C K, Cramer D W. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod, 1999, 14: 409-415.
164. Hartge P. Genetics of reproductive lifespan. Nat Genet, 2009, 41: 637-638.
165. Kok H S, van Asselt K M, van der Schouw Y T, et al. Genetic studies to identify genes underlying menopausal age. Hum Reprod Update, 2005, 11: 483-493.